186 related articles for article (PubMed ID: 21209863)
1. Recombinant expression, purification, and functional characterisation of connective tissue growth factor and nephroblastoma-overexpressed protein.
Bohr W; Kupper M; Hoffmann K; Weiskirchen R
PLoS One; 2010 Dec; 5(12):e16000. PubMed ID: 21209863
[TBL] [Abstract][Full Text] [Related]
2. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
3. Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage.
Kawaki H; Kubota S; Suzuki A; Lazar N; Yamada T; Matsumura T; Ohgawara T; Maeda T; Perbal B; Lyons KM; Takigawa M
J Bone Miner Res; 2008 Nov; 23(11):1751-64. PubMed ID: 18597638
[TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation.
Kaasbøll OJ; Gadicherla AK; Wang JH; Monsen VT; Hagelin EMV; Dong MQ; Attramadal H
J Biol Chem; 2018 Nov; 293(46):17953-17970. PubMed ID: 30262666
[TBL] [Abstract][Full Text] [Related]
5. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor β controls CCN3 expression in nucleus pulposus cells of the intervertebral disc.
Tran CM; Smith HE; Symes A; Rittié L; Perbal B; Shapiro IM; Risbud MV
Arthritis Rheum; 2011 Oct; 63(10):3022-31. PubMed ID: 21618206
[TBL] [Abstract][Full Text] [Related]
7. Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation.
Liu C; Liu XJ; Crowe PD; Kelner GS; Fan J; Barry G; Manu F; Ling N; De Souza EB; Maki RA
Gene; 1999 Oct; 238(2):471-8. PubMed ID: 10570975
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina.
Hughes JM; Kuiper EJ; Klaassen I; Canning P; Stitt AW; Van Bezu J; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Diabetologia; 2007 May; 50(5):1089-98. PubMed ID: 17333105
[TBL] [Abstract][Full Text] [Related]
9. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
10. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
11. Roles of heterotypic CCN2/CTGF-CCN3/NOV and homotypic CCN2-CCN2 interactions in expression of the differentiated phenotype of chondrocytes.
Hoshijima M; Hattori T; Aoyama E; Nishida T; Yamashiro T; Takigawa M
FEBS J; 2012 Oct; 279(19):3584-3597. PubMed ID: 22812570
[TBL] [Abstract][Full Text] [Related]
12. Molecular and Genetic Interactions between CCN2 and CCN3 behind Their Yin-Yang Collaboration.
Kubota S; Kawata K; Hattori T; Nishida T
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682564
[TBL] [Abstract][Full Text] [Related]
13. CCN3, a key matricellular protein, distinctly inhibits TGFβ1-mediated Smad1/5/8 signalling in human podocyte culture.
Madne TH; Dockrell MEC
Cell Mol Biol (Noisy-le-grand); 2018 Feb; 64(3):5-10. PubMed ID: 29506624
[TBL] [Abstract][Full Text] [Related]
14. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
[TBL] [Abstract][Full Text] [Related]
15. N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan.
Aoyama E; Hattori T; Hoshijima M; Araki D; Nishida T; Kubota S; Takigawa M
Biochem J; 2009 May; 420(3):413-20. PubMed ID: 19298220
[TBL] [Abstract][Full Text] [Related]
16. A role for CCN3 (NOV) in calcium signalling.
Li CL; Martinez V; He B; Lombet A; Perbal B
Mol Pathol; 2002 Aug; 55(4):250-61. PubMed ID: 12147716
[TBL] [Abstract][Full Text] [Related]
17. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
[TBL] [Abstract][Full Text] [Related]
18. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
Borkham-Kamphorst E; van Roeyen CR; Van de Leur E; Floege J; Weiskirchen R
J Cell Commun Signal; 2012 Mar; 6(1):11-25. PubMed ID: 21748432
[TBL] [Abstract][Full Text] [Related]
19. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
Yu C; Le AT; Yeger H; Perbal B; Alman BA
J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
[TBL] [Abstract][Full Text] [Related]
20. CCN proteins: multifunctional signalling regulators.
Perbal B
Lancet; 2004 Jan; 363(9402):62-4. PubMed ID: 14723997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
